These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 21204255)
1. Endothelin-1- and isoproterenol-induced differential protein expression and signaling pathway in HL-1 cardiomyocytes. Hong HM; Song EJ; Oh E; Kabir MH; Lee C; Yoo YS Proteomics; 2011 Jan; 11(2):283-97. PubMed ID: 21204255 [TBL] [Abstract][Full Text] [Related]
2. Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy. Cheng TH; Shih NL; Chen CH; Lin H; Liu JC; Chao HH; Liou JY; Chen YL; Tsai HW; Chen YS; Cheng CF; Chen JJ J Biomed Sci; 2005; 12(1):123-33. PubMed ID: 15864745 [TBL] [Abstract][Full Text] [Related]
3. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes. Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329 [TBL] [Abstract][Full Text] [Related]
4. Identification of proteins responding to adrenergic receptor subtype-specific hypertrophy in cardiomyocytes by proteomic approaches. Liu N; Gong KZ; Cai YB; Li Z Biochemistry (Mosc); 2011 Oct; 76(10):1140-6. PubMed ID: 22098239 [TBL] [Abstract][Full Text] [Related]
5. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation. Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704 [TBL] [Abstract][Full Text] [Related]
6. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway. Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes. Zhou J; Xu X; Liu JJ; Lin YX; Gao GD Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1191-8. PubMed ID: 17880376 [TBL] [Abstract][Full Text] [Related]
9. Effects of dl-praeruptorin A on cultured neonatal rat ventricular cardiomyocytes with hypertrophy induced by endothelin-1. Tu X; Miao L; Kang Y; Xia H; Tu JW; Wang Q; Tu Q; Wang JM; Hao H Methods Find Exp Clin Pharmacol; 2009 May; 31(4):231-6. PubMed ID: 19557200 [TBL] [Abstract][Full Text] [Related]
10. Phosphoproteome analysis of cardiomyocytes subjected to beta-adrenergic stimulation: identification and characterization of a cardiac heat shock protein p20. Chu G; Egnaczyk GF; Zhao W; Jo SH; Fan GC; Maggio JE; Xiao RP; Kranias EG Circ Res; 2004 Feb; 94(2):184-93. PubMed ID: 14615292 [TBL] [Abstract][Full Text] [Related]
11. Parallel signaling pathways in endothelin-1-induced proliferation of U373MG astrocytoma cells. He S; Dibas A; Yorio T; Prasanna G Exp Biol Med (Maywood); 2007 Mar; 232(3):370-84. PubMed ID: 17327470 [TBL] [Abstract][Full Text] [Related]
12. Insulin resistance affects the cytoprotective effect of insulin in cardiomyocytes through an impairment of MAPK phosphatase-1 expression. Morisco C; Marrone C; Trimarco V; Crispo S; Monti MG; Sadoshima J; Trimarco B Cardiovasc Res; 2007 Dec; 76(3):453-64. PubMed ID: 17698050 [TBL] [Abstract][Full Text] [Related]
13. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Xu FP; Chen MS; Wang YZ; Yi Q; Lin SB; Chen AF; Luo JD Circulation; 2004 Sep; 110(10):1269-75. PubMed ID: 15313952 [TBL] [Abstract][Full Text] [Related]
14. Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway. Merten KE; Jiang Y; Feng W; Kang YJ J Pharmacol Exp Ther; 2006 Nov; 319(2):934-40. PubMed ID: 16926266 [TBL] [Abstract][Full Text] [Related]
15. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities. Lu YM; Shioda N; Han F; Kamata A; Shirasaki Y; Qin ZH; Fukunaga K Cardiovasc Ther; 2009; 27(1):17-27. PubMed ID: 19207476 [TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin inhibits norepinephrine-induced cardiac hypertrophy via suppression of Gh. Choi EY; Chang W; Lim S; Song BW; Cha MJ; Kim HJ; Choi E; Jang Y; Chung N; Hwang KC Eur J Pharmacol; 2010 Feb; 627(1-3):56-62. PubMed ID: 19883640 [TBL] [Abstract][Full Text] [Related]
19. Signaling pathways activated by vasoactive peptides in the cardiac myocyte and their role in myocardial pathologies. Sugden PH J Card Fail; 2002 Dec; 8(6 Suppl):S359-69. PubMed ID: 12555146 [TBL] [Abstract][Full Text] [Related]
20. Role of endothelin-1, sodium hydrogen exchanger-1 and mitogen activated protein kinase (MAPK) activation in glucose-induced cardiomyocyte hypertrophy. Chen S; Khan ZA; Karmazyn M; Chakrabarti S Diabetes Metab Res Rev; 2007 Jul; 23(5):356-67. PubMed ID: 17024690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]